The estimated Net Worth of Mark W Sawicki is at least $699 mil dollars as of 25 March 2024. Dr Sawicki owns over 1,367 units of CryoPort Inc stock worth over $603,289 and over the last 4 years he sold CYRX stock worth over $95,727.
Dr has made over 8 trades of the CryoPort Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,367 units of CYRX stock worth $23,977 on 25 March 2024.
The largest trade he's ever made was exercising 94,202 units of CryoPort Inc stock on 11 August 2021 worth over $748,906. On average, Dr trades about 13,640 units every 111 days since 2021. As of 25 March 2024 he still owns at least 77,444 units of CryoPort Inc stock.
You can see the complete history of Dr Sawicki stock trades at the bottom of the page.
Dr. Mark W. Sawicki Ph.D. is the Pres & CEO of Cryoport Systems at CryoPort Inc.
Mark's mailing address filed with the SEC is C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027.
Over the last 12 years, insiders at CryoPort Inc have traded over $202,268,038 worth of CryoPort Inc stock and bought 80,292 units worth $196,910 . The most active insiders traders include Holdings Ii L.P.Blackstone ..., Richard J Berman y Jerrell Shelton. On average, CryoPort Inc executives and independent directors trade stock every 39 days with the average trade being worth of $414,958. The most recent stock trade was executed by Robert J Hariri on 19 August 2024, trading 1,000 units of CYRX stock currently worth $9,470.
cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
CryoPort Inc executives and other stock owners filed with the SEC include: